Diego Adrianzen Herrera (Diego A Adrianzen-Herrera, Diego Andres Adrianzen-Herrera, Diego Adrianzen-Herrera)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Peripheral Blood

Cardiovascular Disease

Top Venues

Leukemia & lymphoma

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer medicine

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Adrianzen Herrera, Andrew D Sparks, Rohit Singh, David Alfonso Alejos Castillo, Akshee Batra, Shira Gabriella Glushakow-Smith, Kith Pradhan, Aditi Shastri, Neil A Zakai
Impact of Preexisting Autoimmune Disease on Myelodysplastic Syndromes Outcomes: A population Analysis. Blood advances (2023)
Diego Adrianzen Herrera, Andrew D Sparks, Akshee Batra, Neil A Zakai
Survival gains in myelodysplastic syndromes following a decade of the modern treatment paradigm. Leukemia & lymphoma (2023)
Katherine Giorgio, Rob F Walker, Richard F MacLehose, Diego Adrianzen Herrera, Wendy Wang, Alvaro Alonso, Neil A Zakai, Pamela L Lutsey
Venous thromboembolism mortality and trends in older US adults, 2011-2019. American journal of hematology (2023)
Diego Adrianzen Herrera, Insu Koh, Radhika Gangaraju, Tomi F Akinyemiju, Neil A Zakai
Association between peripheral blood cytopenia and cancer mortality: A race-specific risk factor for cancer death. Cancer medicine (2022)
Diego Adrianzen Herrera, Insu Koh, Radhika Gangaraju, Tomi F Akinyemiju, Neil A Zakai
Association between peripheral blood cytopenia and cancer mortality: A race-specific risk factor for cancer death. Cancer medicine (2022)
Diego Adrianzen Herrera, Aditi Shastri
Unrelated Allogeneic Stem Cell Transplant in Relapsed/Refractory AML: Widening the Yellow Brick Road. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Steven Ades, Diego Adrianzen Herrera, Tim Lahey, Alissa A Thomas, Sakshi Jasra, Maura M Barry, Julian R Sprague, Kim Dittus, Timothy B Plante, Jamie Kelly, Peter A Kaufman, Farrah Khan, Cory J Hammond, Kelly Gernander, Polly Parsons, Chris Holmes
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect. JCO oncology practice (2021)
Radhika Gangaraju, Insu Koh, Marguerite R Irvin, Leslie Lange, Damon E Houghton, Diego Adrianzen Herrera, Monika M Safford, Andrea N Edginton, Smita Bhatia, Neil A Zakai
Peripheral Blood Cytopenia and Risk of Cardiovascular Disease and Mortality. Journal of the American Heart Association 10 (18) (2021)
Aditi Shastri, Diego Adrianzen Herrera
Ruxolitinib in CMML: A Case Study of Innovative Trial Design in a Rare Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Mansour Gergi, Kara K Landry, Steven Ades, Maura Barry, Neil A Zakai, Diego Adrianzen Herrera
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy. The oncologist 25 (12) (2020)
Diego Adrianzen Herrera, Gaurav Choudhary, Shanisha Gordon-Mitchell, Nandini Ramachandra, Tushar Bhagat, Hui Zhang, Srinivas Aluri, Aditi Shastri, Ulrich Steidl, Britta Will, Weng-Lang Yang, Michelle Mahler, Gary Eichenbaum, Chandan Guha, Amit K Verma
The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation. Leukemia & lymphoma 61 (10) (2020)